1834 Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-200
| Closed | -$12K | – | 247 |
|
|
2022
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 366 |
|
|
2022
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 335 |
|
|
2021
Q4 | $15K | Hold |
200
| – | – | ﹤0.01% | 348 |
|
|
2021
Q3 | $22K | Hold |
200
| – | – | ﹤0.01% | 333 |
|
|
2021
Q2 | $32K | Hold |
200
| – | – | ﹤0.01% | 307 |
|
|
2021
Q1 | $24K | Hold |
200
| – | – | ﹤0.01% | 310 |
|
|
2020
Q4 | $31K | Hold |
200
| – | – | ﹤0.01% | 290 |
|
|
2020
Q3 | $17K | Hold |
200
| – | – | ﹤0.01% | 312 |
|
|
2020
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 302 |
|
|
2020
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 336 |
|
|
2019
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 364 |
|
|
2019
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 397 |
|
|
2019
Q2 | $9K | Hold |
200
| – | – | ﹤0.01% | 377 |
|
|
2019
Q1 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 365 |
|